Maxcyte (DI) (MXCT)

Index:

FTSE AIM 100

 295.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 420.00p
  • 52 Week Low: 210.00p
  • Currency: UK Pounds
  • Shares Issued: 104.40m
  • Volume: 5,668
  • Market Cap: £307.97m

Latest ShareCast News

MaxCyte reports strong fourth quarter as full-year revenues fall

By Josh White

Date: Wednesday 13 Mar 2024

(Sharecast News) - Cell engineering technology specialist MaxCyte reported total fourth quarter revenue of $15.7m on Wednesday, up 26% on the same period in 2022.

MaxCyte flags lower 2023 revenue, flat 2024 growth

By Josh White

Date: Tuesday 05 Mar 2024

(Sharecast News) - Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41.1m and $41.3m, down from $44.3m in 2022.

MaxCyte flags uptick in total fourth-quarter revenue

By Josh White

Date: Tuesday 09 Jan 2024

(Sharecast News) - Cell engineering company MaxCyte said on Tuesday that total fourth-quarter revenue was expected to be between $15.5m and $15.7m.

Maher Masoud starts as MaxCyte president, CEO 02-Jan-2024 ShareCast
MaxCyte announces new CEO, updates revenue guida... 12-Dec-2023 ShareCast
MaxCyte joins Alliance for mRNA Medicines 16-Nov-2023 ShareCast
MaxCyte lowers full-year guidance after weaker t... 05-Oct-2023 ShareCast
MaxCyte signs licence deal with Vittoria Biother... 10-Jul-2023 ShareCast
MaxCyte inks platform licensing deal with Lyell 06-Jul-2023 ShareCast
MaxCyte revises guidance after weaker first quar... 11-May-2023 ShareCast
MaxCyte installs Douglas Swirsky as its new fina... 28-Mar-2023 ShareCast
MaxCyte expecting strong 2023 after decent results 16-Mar-2023 ShareCast
MaxCyte flags 2022 revenue growth, sets new guid... 07-Mar-2023 ShareCast
MaxCyte signs strategic platform licence with Ca... 04-Jan-2023 ShareCast
MaxCyte inks deal with South Korea's Curamys 05-Dec-2022 ShareCast
MaxCyte revenues improve in third quarter 10-Nov-2022 ShareCast
MaxCyte hikes guidance after solid first half 11-Aug-2022 ShareCast
MaxCyte reports good first quarter revenue growth 10-May-2022 ShareCast
MaxCyte CFO resigns, first quarter revenues rise 13-Apr-2022 ShareCast
MaxCyte reports record Q4 and full-year revenue 23-Mar-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 295.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 420.00p
52 Week Low 210.00p
Volume 5,668
Shares Issued 104.40m
Market Cap £307.97m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 26-Apr-2024

Time Volume / Share Price
16:20 5,000 @ 290.00p
14:30 550 @ 300.00p
11:05 118 @ 298.00p

Top of Page